TP53 and central nervous system cancer: Genetic modeling of this GBM subtype in mice achieved by deleting NF1, TP53 and/or PTEN in nestin-expressing cells (NSCs/PC) and GFAP-expressing cells (NSCs and white matter astrocytes) results in tumors histologically identical to human gliomas [12].